Clinical Trial Update: Nitric Oxide Donors for Treatment of Isolated Oligohydramnios [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating nitric oxide donors for the treatment of isolated idiopathic oligohydramnios has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligohydramnios

Drugs mentioned

• Nitric Oxide donors (nitric oxide donor(s))

Snippet

Sponsor: Benha University | Conditions: Isolated (Idiopathic) Oligohydramnios | Phase 2, Phase 3 | Status: COMPLETED